SCHEMBL7377977

SCHEMBL7377977

CC(C)(C)OC(=O)CN(Cc1ccncc1)S(=O)(=O)c1ccc2c(NC(N)=NCl)cncc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.36
MMP1 P03956 3/20 0.36
MMP2 P08253 3/20 0.36
MMP9 P14780 3/20 0.36
MMP8 P22894 3/20 0.36
MMP13 P45452 3/20 0.36
ALDH1A1 P00352 5/20 0.35
KDM4E B2RXH2 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
PKM P14618 1/20 0.35
HTT P42858 1/20 0.35
RECQL P46063 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HSD17B10 Q99714 1/20 0.35
NR1D1 P20393 2/20 0.34
MAPT P10636 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7049646 0.94 PLAU (0.43) PLAUMMP1MMP2MMP9MMP8
SCHEMBL7375649 0.92 NR1D1 (0.35) PLAUMMP1MMP2MMP9MMP8
SCHEMBL7378343 0.92 PDE4A (0.41) PLAUMMP1MMP2MMP9MMP8
SCHEMBL7367643 0.92 ALDH1A1 (0.41) MMP1MMP2MMP9MMP8MMP13
SCHEMBL7371411 0.90 MAPT (0.39) PLAUMMP1MMP2MMP9MMP8
SCHEMBL7371892 0.88 TAS2R14 (0.40) PLAUMMP2MMP9MMP13ALDH1A1
SCHEMBL7378428 0.88 PDE4A (0.38) PLAUALDH1A1SMN1; SMN2HTTHSD17B10
SCHEMBL6436326 0.87 SMN1; SMN2 (0.37) PLAUMMP1MMP2MMP9MMP8
SCHEMBL7050066 0.86 PLAU (0.39) PLAUALDH1A1SMN1; SMN2HTTNPSR1
SCHEMBL7369748 0.85 PLG (0.44) PLAUALDH1A1HTTNPSR1PTGER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242120-A2 COMBINATIONS OF GROWTH FACTORS AND I:UPA OR I:MMP FOR THE TREATMENT OF DAMAGED TISSUE Pfizer Limited (GB) 2002-09-25 EP disclosed
WO-2001049309-A2 COMBINATIONS OF GROWTH FACTORS AND I: UPA OR I: MMP FOR THE TREATMENT OF DAMAGED TISSUE PFIZER LIMITED (GB) 2001-07-12 WO disclosed
EP-1077945-A1 ISOQUINOLINES AS UROKINASE INHIBITORS PFIZER INC. (US) 2001-02-28 EP disclosed
WO-2000005214-A2 ISOQUINOLINES AS UROKINASE INHIBITORS PFIZER INC. (US) 2000-02-03 WO disclosed